Published in Infect Immun on May 01, 1989
Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev (1999) 7.76
Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev (2005) 2.36
Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect Immun (1991) 1.97
Phenotypic diversity in the alpha C protein of group B streptococci. Infect Immun (1991) 1.64
Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein. Infect Immun (1992) 1.58
Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. J Clin Invest (1994) 1.19
Identification of an immunoglobulin A binding motif located in the beta-antigen of the c protein complex of group B streptococci. Infect Immun (1996) 0.91
High expression of a C protein beta antigen gene among invasive strains from certain clonally related groups of type Ia and Ib group B streptococci. Infect Immun (2002) 0.88
Nonimmune binding of human immunoglobulin A to type II group B streptococci. Infect Immun (1990) 0.84
Human Siglec-5 inhibitory receptor and immunoglobulin A (IgA) have separate binding sites in streptococcal beta protein. J Biol Chem (2011) 0.84
Inactivation of DNA-binding response regulator Sak189 abrogates beta-antigen expression and affects virulence of Streptococcus agalactiae. PLoS One (2010) 0.79
Colloidal gold immunolabeling of immunoglobulin-binding sites and beta antigen in group B streptococci. Infect Immun (1990) 0.79
Natural Mutations in Streptococcus agalactiae Resulting in Abrogation of β Antigen Production. PLoS One (2015) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Group B streptococcal neonatal and infant infections. J Pediatr (1973) 10.25
"Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin. J Immunol (1966) 9.65
Transmission of group B streptococci among parturient women and their neonates. J Pediatr (1973) 6.86
Type-specific antigens of group B type Ic streptococci. Infect Immun (1971) 6.84
Standardization and evaluation of the CAMP reaction for the prompt, presumptive identification of Streptococcus agalactiae (Lancefield group B) in clinical material. J Clin Microbiol (1975) 3.38
The IgA1 proteases of pathogenic bacteria. Annu Rev Microbiol (1983) 3.29
A surface component in group A, C, and G streptococci with non-immune reactivity for immunoglobulin G. J Immunol (1973) 3.23
Serological relationships of type I antigens of group B streptococci. J Bacteriol (1969) 2.67
Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes. J Clin Microbiol (1984) 2.55
Group B streptococcal infection in humans. Annu Rev Microbiol (1978) 1.95
A surface receptor specific for human IgA on group B streptococci possessing the Ibc protein antigen. J Exp Med (1984) 1.70
Complete covalent structure of a human IgA1 immunoglobulin. Science (1976) 1.67
Group B streptococcal colonization patterns in mothers and their infants. J Clin Microbiol (1984) 1.64
Reduction of morbidity and mortality rates for neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis. J Clin Microbiol (1986) 1.55
Complete and incomplete Ibc protein fraction in group B streptococci. Acta Pathol Microbiol Scand B (1979) 1.52
Worldwide distribution of two new serotypes of group B streptococci: type IV and provisional type V. J Clin Microbiol (1985) 1.50
Ibc proteins as serotype markers of group B streptococci. Acta Pathol Microbiol Immunol Scand B (1983) 1.35
Prospective studies of group B streptococcal infections in infants. J Pediatr (1979) 1.34
Streptococcal Fc receptors. I. Isolation and partial characterization of the receptor from a group C streptococcus. J Immunol (1984) 1.33
Identification of protein antigens of group B streptococci, with special reference to the Ibc antigens. J Exp Med (1984) 1.20
Effect of mouse passage on Fc receptor expression by group A streptococci. Scand J Immunol (1984) 1.15
Unspecific binding of group B streptococcal cocytolysin (CAMP factor) to immunoglobulins and its possible role in pathogenicity. J Exp Med (1987) 1.13
Isolation of a C (Ibc) protein from group B Streptococcus which elicits mouse protective antibody. Microb Pathog (1986) 1.10
Isolation and some properties of an IgG Fc-binding protein from group A streptococci type 15. Int Arch Allergy Appl Immunol (1982) 1.08
The Ibc protein fraction of group B streptococci: characterization of protein antigens extracted by HCL. Acta Pathol Microbiol Scand B (1981) 1.07
Two novel antigens associated with group B streptococci identified by a rapid two-stage radioimmunoassay. J Infect Dis (1988) 1.07
Cloning and expression in Escherichia coli of the Ibc protein genes of group B streptococci: binding of human immunoglobulin A to the beta antigen. Infect Immun (1987) 1.04
Detection of receptors for the Fc region of IgG on streptococci. J Immunol Methods (1983) 0.99
The Ibc proteins of group B streptococci: isolation of the alpha and beta antigens by immunosorbent chromatography and test for human serum antibodies against the two antigens. Acta Pathol Microbiol Immunol Scand B (1985) 0.93
Use of labeled protein A in quantitative immunochemical analysis of antigens and antibodies. J Immunol Methods (1982) 0.87
The Ibc proteins of group B streptococci: trypsin extracted alpha antigen and detection of the alpha and beta antigens. Acta Pathol Microbiol Immunol Scand B (1983) 0.86
Serotypes of group B streptococci in urogenital patients. Scand J Infect Dis (1980) 0.84
GBS colonisation in mothers and babies. Antibiot Chemother (1971) (1985) 0.78
IgG-Fc-receptors in T-type 12 group A streptococci from clinical specimens: absence from M-type 12 and presence in M-type 22. Acta Pathol Microbiol Scand B (1981) 0.77
Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a small RNA molecule. Mol Microbiol (2001) 2.24
Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol (1992) 2.14
Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model. Infect Immun (1993) 1.92
Capturing host plasmin(ogen): a common mechanism for invasive pathogens? Trends Microbiol (1994) 1.76
Identification of a specific receptor for plasmin on a group A streptococcus. Infect Immun (1987) 1.72
M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes. Mol Microbiol (1996) 1.71
Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J Bacteriol (1999) 1.39
Isolation of a prokaryotic plasmin receptor. Relationship to a plasminogen activator produced by the same micro-organism. J Biol Chem (1991) 1.38
A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol (1998) 1.36
Streptococcal Fc receptors. I. Isolation and partial characterization of the receptor from a group C streptococcus. J Immunol (1984) 1.33
Characterization of the interaction of human plasmin with its specific receptor on a group A streptococcus. Microb Pathog (1988) 1.20
Isolation and characterization of type IIa and type IIb Fc receptors from a group A streptococcus. Scand J Immunol (1986) 1.18
Effect of mouse passage on Fc receptor expression by group A streptococci. Scand J Immunol (1984) 1.15
Streptokinase-producing streptococci grown in human plasma acquire unregulated cell-associated plasmin activity. J Infect Dis (1992) 1.15
Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64. Infect Immun (2000) 1.13
Protection of mice from group A streptococcal skin infection by interleukin-12. J Infect Dis (1995) 1.12
125I protein A: applications to the quantitative determination of fluid phase and cell-bound IgG. J Immunol Methods (1977) 1.10
Association of type II immunoglobulin G-binding protein expression and survival of group A streptococci in human blood. Infect Immun (1993) 1.10
Studies on the terminal stages of immune hemolysis. VI. Osmotic blockers of differing Stokes' radii detect complement-induced transmembrane channels of differing size. J Immunol (1979) 1.09
Functional and serological analysis of type II immunoglobulin G-binding proteins expressed by pathogenic group A streptococci. J Clin Microbiol (1992) 1.08
Two novel antigens associated with group B streptococci identified by a rapid two-stage radioimmunoassay. J Infect Dis (1988) 1.07
Measurement of leukocyte chemotaxis in vivo. Methods Enzymol (1988) 1.07
Isolation and partial characterization of a type II Fc receptor from a group A streptococcus. Mol Cell Biochem (1986) 1.07
Streptococcal Fc receptors. II. Comparison of the reactivity of a receptor from a group C streptococcus with staphylococcal protein A. J Immunol (1984) 1.06
Evidence for functional heterogeneity in IgG Fc-binding proteins associated with group A streptococci. J Immunol (1991) 1.05
Group B streptococcal C protein-associated antigens: association with neonatal sepsis. J Infect Dis (1991) 1.04
Identification of two type IIa IgG-binding proteins expressed by a single group A streptococcus. J Immunol (1992) 1.02
Mapping of the human plasmin domain recognized by the unique plasmin receptor of group A streptococci. Infect Immun (1989) 1.02
Studies on the terminal stages of immune hemolysis. III. Distinction between the insertion of C9 and the formation of a transmembrane channel. J Immunol (1978) 1.02
Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model. J Infect Dis (1999) 0.99
Properties of IgG-binding proteins expressed by Streptococcus pyogenes isolates are predictive of invasive potential. J Infect Dis (1996) 0.99
Detection of receptors for the Fc region of IgG on streptococci. J Immunol Methods (1983) 0.99
Isolated DNA repeat region from fcrA76, the Fc-binding protein gene from an M-type 76 strain of group A streptococci, encodes a protein with Fc-binding activity. Mol Microbiol (1990) 0.99
Identification of a unique receptor on a group A streptococcus for the Fc region of human IgG3. J Immunol (1986) 0.98
A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci. J Infect Dis (1995) 0.98
The potential role for nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. Methods (2000) 0.98
A group A streptococcal Enn protein potentially resulting from intergenomic recombination exhibits atypical immunoglobulin-binding characteristics. Mol Microbiol (1994) 0.97
Analysis of the interaction of group A streptococci with fibrinogen, streptokinase and plasminogen. Microb Pathog (1995) 0.97
Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol (1985) 0.96
Studies on the interaction between protein A and immunoglobulin G. II. Composition and activity of complexes formed between protein A and IgG. J Immunol (1978) 0.96
Studies on the terminal stages of immune hemolysis. V. Evidence that not all complement-produced transmembrane channels are equal. J Immunol (1979) 0.96
Differences in cell-bound C8 sites on chicken erythrocytes measured by their reactivity with guinea pig and human C9. J Immunol (1980) 0.95
Identification of key gene products required for acquisition of plasmin-like enzymatic activity by group A streptococci. J Infect Dis (1997) 0.95
Mouse skin passage of a Streptococcus pyogenes Tn917 mutant of sagA/pel restores virulence, beta-hemolysis and sagA/pel expression without altering the position or sequence of the transposon. BMC Microbiol (2001) 0.95
Lysis of tumor cells by antibody and complement. VII. Complement-dependent 86Rb release--a nonlethal event? J Immunol (1976) 0.94
Production of Brucella abortus-specific protein A-reactive antibodies (IgG2) in infected and vaccinated cattle. Vet Microbiol (1986) 0.94
Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci U S A (1983) 0.94
Analysis of plasmin(ogen) acquisition by clinical isolates of group A streptococci incubated in human plasma. J Infect Dis (1994) 0.94
Urokinase: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol (1987) 0.93
A simple procedure to use whole serum as a source of either IgG- or IgM-specific antibody. J Immunol Methods (1980) 0.92
Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. II. Inhibition of transformation of T to dead cells by 3'5' cAMP. J Immunol (1976) 0.92
Similarities between complement-mediated and streptolysin S-mediated hemolysis. J Biol Chem (2001) 0.91
Analysis of surface receptor expression on bacteria isolated from patients with endocarditis. J Gen Microbiol (1986) 0.90
Interaction between components of the human classical complement pathway and immobilized Cibacron Blue F3GA. J Immunol Methods (1979) 0.90
Streptococcal pyrogenic exotoxin B enhances tissue damage initiated by other Streptococcus pyogenes products. J Infect Dis (2001) 0.90
The terminal stages of immune hemolysis--a brief review. Mol Immunol (1980) 0.89
A rapid technique for measuring leukocyte chemotaxis in vivo. J Immunol Methods (1984) 0.89
Species specificity of plasminogen activation and acquisition of surface-associated proteolytic activity by group C streptococci grown in plasma. Infect Immun (1999) 0.89
Identification of protein A from Staphylococcus intermedius isolated from canine skin. Am J Vet Res (1988) 0.89
Analysis of expression of a cytosolic enzyme on the surface of Streptococcus pyogenes. Biochem Biophys Res Commun (2000) 0.88
Studies on the terminal stages of immune hemolysis. IV. Effect of metal salts. J Immunol (1979) 0.88
Analysis of immunoglobulin G-binding-protein expression by invasive isolates of Streptococcus pyogenes. Clin Diagn Lab Immunol (1995) 0.88
Interaction of a group A Streptococcus within human plasma results in assembly of a surface plasminogen activator that contributes to occupancy of surface plasmin-binding structures. Microb Pathog (1998) 0.87
Lysis of tumor cells by antibody and complement. VI. Enhanced killing of enzyme-pretreated tumor cells. J Immunol (1976) 0.87
A pivotal role for interferon-gamma in protection against group A streptococcal skin infection. J Infect Dis (2000) 0.86
Comparison of type III Fc receptors associated with group C and group G streptococci. Mol Immunol (1986) 0.86
Distinct profiles of immunoglobulin G-binding-protein expression by invasive serotype M1 isolates of Streptococcus pyogenes. Clin Diagn Lab Immunol (1995) 0.85
Studies on the interaction between protein A and immunoglobulin G. I. Effect of protein A on the functional activity of IgG. J Immunol (1978) 0.85
Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. I. Evidence for the existence of an intermediate, T. J Immunol (1976) 0.85
Results of the premature birth national need-gap study. J Perinatol (2007) 0.85
Restoration of complement function in vivo by plasma infusion in factor I (C3b inactivator) deficiency. J Pediatr (1984) 0.84
Enzyme-labeled type III bacterial Fc receptors. A versatile tracer for immunoassay. J Immunol Methods (1988) 0.84
Identification of distinct Fc-receptor molecules on streptococci and staphylococci. J Clin Lab Immunol (1984) 0.84
Distinction between C8-mediated and C8/C9-mediated hemolysis on the basis of independent 86Rb and hemoglobin release. J Immunol (1980) 0.84
Role of staphylokinase in the acquisition of plasmin(ogen)-dependent enzymatic activity by staphylococci. J Infect Dis (1996) 0.84
Inactivation of single genes within the virulence regulon of an M2 group A streptococcal isolate result in differences in virulence for chicken embryos and for mice. Microb Pathog (1997) 0.84
Detection of streptococcal class I M protein in psoriasis by confocal immunofluorescent microscopy. Acta Derm Venereol (1997) 0.83
Interaction of group A streptococci with human plasmin(ogen) under physiological conditions. Methods (2000) 0.83
The destruction of allogeneic tumour cells by antibody and adherent cells from peritoneal cavities of mice. Cell Immunol (1976) 0.83
Group A streptococci bind human plasmin but not other structurally related proteins. Thromb Res (1989) 0.82
The destruction of tumor cells by alloimmune peritoneal cells: mechanism of action of activated macrophages in vitro. J Reticuloendothel Soc (1975) 0.82
Group A streptococcal isolate 64/14 expresses surface plasmin-binding structures in addition to Plr. Res Microbiol (1998) 0.81
Nerve growth factor: activation of the classical complement pathway by specific substitution for component C1-. Proc Natl Acad Sci U S A (1982) 0.81
Evidence for a temperature-dependent and temperature-independent pathway in the generation of complement-mediated transmembrane channels. Biochem Biophys Res Commun (1980) 0.80
Different alleles of the fcrA/mrp gene of Streptococcus pyogenes encode M-related proteins exhibiting an identical immunoglobulin-binding pattern. Med Microbiol Immunol (1996) 0.80
The destruction of allogeneic tumour cells by peritoneal macrophages from immune mice: purification of lytic effector cells. Cell Immunol (1975) 0.80
Comparison of albumin receptors expressed on bovine and human group G streptococci. Infect Immun (1991) 0.80
Colloidal gold immunolabeling of immunoglobulin-binding sites and beta antigen in group B streptococci. Infect Immun (1990) 0.79
Characterization of a type II'o group A streptococcal immunoglobulin-binding protein. Mol Immunol (1995) 0.79
Inactivation of the proteolytic activity of mouse nerve growth factor by human C1(activated)-inhibitor. J Immunol (1987) 0.79
The interaction of pathogens with humans. Methods (2000) 0.79
Antibody-complement killing of neuroblastoma cells. Prog Clin Biol Res (1985) 0.79
Subunit structure of high molecular weight mouse nerve growth factor. Biochemistry (1988) 0.78
Complement-dependent cytotoxic antitumor antibody. I. Immunoglobulin class determined by interaction with protein A or concanavalin A. J Natl Cancer Inst (1978) 0.78
Effect of concanavalin A on the hemolytic activity of the components of the classical complement pathway. Mol Immunol (1980) 0.78
Effect of concanavalin A on the functional activity of hemolytic antibody. Immunol Commun (1977) 0.78
Is the membrane attack complex of complement an enzyme? Mol Cell Biochem (1984) 0.78
Effect of concanavalin A on the classical complement pathway. J Immunol (1977) 0.78
Purging tumor cells from bone marrow by use of antibody and complement: a critical appraisal. J Natl Cancer Inst (1988) 0.78
Destruction of allogeneic tumour cells by peritoneal macrophages. Transplantation (1976) 0.78